Physician profile
Colin Patrick Ryan
NPI 1417481771
$12,232.07
in general payments reported to CMS, 2019-2025
36 companies · $3,755 in 2025
The $3,755 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $394 · 2023: $1,224 · 2024: $6,859 · 2025: $3,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,676 · Travel and Lodging: $4,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,676.40 |
| Travel and Lodging | $4,161.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,118.07 | 2023-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $2,218.54 | 2024-2025 | Aquabeam System |
| Laborie Medical Technologies Corp. | $780.25 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Dendreon Pharmaceuticals LLC | $713.38 | 2023-2025 | Provenge |
| Sumitomo Pharma America, INC. | $681.47 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $567.47 | 2022-2025 | |
| Astellas Pharma US INC | $474.89 | 2022-2024 | Xtandi, Myrbetriq, Veozah |
| Medtronic, INC. | $405.65 | 2023-2024 | Interstim |
| Boston Scientific Corporation | $324.17 | 2023-2025 | Axonics, General - Therapies, Rezum Generator |
| Janssen Biotech, INC. | $202.37 | 2023-2025 | Erleada |
| Novartis Pharmaceuticals Corporation | $161.61 | 2024-2025 | |
| Pfizer INC. | $150.71 | 2024-2025 | |
| Urogen Pharma, INC. | $147.89 | 2024-2025 | |
| Olympus America INC. | $132.62 | 2024-2025 | Itind System |
| Progenics Pharmaceuticals, INC. | $130.35 | 2023-2025 | Pylarify |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $119.85 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.21 | 2022-2023 | |
| Genzyme Corporation | $94.97 | 2022-2023 | |
| Endo USA, INC. | $94.49 | 2024-2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $74.61 | 2022-2023 | Xiaflex, Aveed |
| Abbvie INC. | $72.09 | 2023-2025 | Botox |
| Accord Healthcare, INC. | $71.09 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $67.88 | 2023-2025 | Lynparza |
| Trevena, INC. | $43.15 | 2023-2024 | Olinvyk |
| Tolmar, INC. | $34.65 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $28.23 | 2025 | |
| Convatec INC. | $27.56 | 2023 | |
| Verity Pharmaceuticals INC. | $27.32 | 2023 | Trelstar |
| Urovant Sciences INC | $27.04 | 2022 | |
| Antares Pharma, INC. | $24.32 | 2025 | Xyosted |
| 180 Medical, INC. | $23.13 | 2023 | |
| Cordis US Corp. | $21.50 | 2024 | Mynx Control |
| Abbott Laboratories | $21.33 | 2025 | Freestyle Libre 3 |
| Foundation Medicine, INC. | $19.87 | 2023 | |
| Merck Sharp & Dohme LLC | $14.35 | 2024 | Keytruda, Welireg |
| Steris Corporation | $13.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.